Hematologic Oncology Cancer Types and Programs

The Center for Hematologic Oncology provides specialized care for all types of cancers of the blood, including leukemia, lymphoma, multiple myeloma, histiocytosis, and Waldenström's macroglobulinemia, as well as related disorders of the blood, such as aplastic anemia and myelodysplasia.

The center also includes the bone marrow/stem cell transplantation program, which is one of the largest and most experienced in the world.

We develop personalized, comprehensive treatment plans for all our patients, offering the latest therapies and supportive resources, and taking your particular needs into account.

Our Specialized Centers and Programs

Amyloidosis Program

The Amyloidosis Program is highly specialized and dedicated to the diagnosis, research, and treatment of this underappreciated and often misdiagnosed disease. Our approach to treatment is unique in that it is grounded in science and laboratory-based discovery. We provide access to clinical trials, innovative therapies, and unparalleled patient-centered care.

Center for Early Detection and Interception of Blood Cancers

The Center for Early Detection and Interception of Blood Cancers (formerly Center for Prevention of Progression) is the first-of-its-kind clinic for patients with precursor conditions of hematologic malignancies. Building on our research of precursor conditions, the clinic evaluates individuals diagnosed with these conditions or at high risk for disease development, and works with patients to manage their risk of disease progression.

Adult Leukemia Program

The Adult Leukemia Program provides care for patients with leukemia and related bone marrow disorders, including acute myeloid leukemia (AML), acute lymphocytic leukemia (ALL), chronic myelogenous leukemia (CML), and related bone marrow disorders, such as myelodysplasia and myelofibrosis.

Acute lymphoblastic leukemia (ALL)
Acute myeloid leukemia (AML)
Chronic myelogenous leukemia (CML)
Adult Bone Marrow Failure Syndromes
Myelodysplastic Syndromes (MDS)
Myeloproliferative Neoplasms (MPNs)

Adult Histiocyte Disorders Center

The Adult Histiocyte Disorders Center provides highly effective, personalized treatment options for patients with adult histiocytosis and histiocyte disorders – rare diseases resulting from over-production of white blood cells (histiocytes), which can lead to tumors and organ damage.


Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Center

The BPDCN Center combines world-class patient care with leading-edge research — providing highly effective, personalized treatment options for patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN), a rare and aggressive hematologic malignancy. Our center is among the first in the U.S. for care and research for patients with BPDCN.

Hematologic malignancies we treat include:

Agnogenic myeloid metaplasia
Aids-related malignancies
Aplastic anemia and paroxysmal nocturnal hemoglobinuria (PNH)
Autoimmune disorders
Burkitt lymphoma
Castleman's syndrome
Chronic myeloid monocytic leukemia (CMML)
CNS primary lymphoma
Congenital disorders of blood production (sickle cell anemia, thalassemia), Blackfan-Diamond, Shwachman-Diamond, and Dyskeratosis Congenita syndromes
Essential thrombocytosis
Hairy cell leukemia
Jak 2 disease
Langerhans cell histiocytosis
Lymphoproliferative disorder
Megaloblastic anemia
Monoclonal gammopathies
Monoclonal paraprotein/M-GUS
Mycosis fungoides/cut-cell lymphoma
Myelodysplastic syndromes (MDS)
Myeloid metaplasia
Myeloproliferative Neoplasms (MPNs)
Neutropenia pancytopenia
NK cell lymphoma
Philadelphia positive disease
Polycythemia vera
Testicular cancer
Testicular choriocarcinoma
Waldenström's macroglobulinemia

Services and Support at Dana-Farber